上海研盟生物有限公司*品質(zhì)供應(yīng)Anti-ANT-1抗體，我公司銷售國內(nèi)外科研產(chǎn)品，如生物試劑、生化試劑，一抗二抗，各種標(biāo)記抗體，Elisa酶聯(lián)免疫試劑盒，放免試劑盒，培養(yǎng)基，各種動物血清等產(chǎn)品，歡迎廣大新老客戶前來咨詢訂購，訂購:或。

腺嘌呤核苷酸轉(zhuǎn)運(yùn)蛋白1抗體,Anti-ANT-1抗體簡單介紹：

中文名稱：腺嘌呤核苷酸轉(zhuǎn)運(yùn)蛋白1抗體

英文名稱：Anti-ANT-1抗體

別 名：heart/skeletal muscle isoform T1; Adenine nucleotide translocator 1 (skeletal muscle); Adenine nucleotide translocator 1; ADP; ADP ATP carrier protein 1; ADP ATP carrier protein heart/skeletal muscle isoform T1; ADP/ATP translocase 1; ADT1_HUMAN; ANT 1; ANT; ANT1; ATP carrier protein 1; ATP carrier protein; MSA02; PEO2; PEO3; SLC25A4; Solute carrier family 25 member 4; T1 antibody.    

此產(chǎn)品本公司有標(biāo)記的一抗出售，相關(guān)標(biāo)記有：Alexa Fluor 350 標(biāo)記、Alexa Fluor 488 標(biāo)記、Alexa Fluor 555 標(biāo)記、Alexa Fluor 647 標(biāo)記、AP標(biāo)記、APC標(biāo)記、Biotin標(biāo)記、Cy3標(biāo)記、Cy5標(biāo)記、Cy5.5標(biāo)記、Cy7標(biāo)記、FITC標(biāo)記、Gold標(biāo)記、HRP標(biāo)記、PE標(biāo)記、PE-Cy3標(biāo)記、PE-CY5標(biāo)記、PE-CY5.5標(biāo)記、PE-CY7標(biāo)記、RBITC標(biāo)記

背景介紹：Defects in SLC25A4 are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283]. Progressive external ophthalmoplegia is characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

規(guī)格：0.1ml/0.2ml

濃度：1mg/1ml

抗體來源：本公司抗體有兔來源和鼠來源等

克隆類型：兔來源為多抗，鼠來源為單抗

產(chǎn)品類型：一抗

腺嘌呤核苷酸轉(zhuǎn)運(yùn)蛋白1抗體保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

避免反復(fù)凍融，保質(zhì)期一年。

腺嘌呤核苷酸轉(zhuǎn)運(yùn)蛋白1抗體,Anti-ANT-1抗體免疫組化問題解答

1、染色過強(qiáng)？

原 因：抗體濃度過高或孵育時(shí)間過長

解決方法：降低抗體滴度、抗體孵育時(shí)間：室溫1小時(shí)或4度過夜

原 因：孵育溫度過高超過37度

解決方法：一般在室溫20-28度

原 因：DAB顯色時(shí)間過長或濃度過高

解決方法：顯色時(shí)間不超過5-12分鐘，以顯微鏡下觀察為準(zhǔn)

2、非特異性背景染色？

原 因：操作過程中沖洗不充分

解決方法：每步?jīng)_洗3次每次5分鐘

原 因：組織中含過氧化物酶未阻斷

解決方法：可再配置新鮮3%H2O2封閉孵育時(shí)間延長

原 因：組織中含內(nèi)原性*

解決方法：正常非免疫動物血清再封閉

原 因：血清蛋白封閉不充分

解決方法：血清蛋白封閉不充分

相關(guān)優(yōu)質(zhì)產(chǎn)品：

SSTR1 (somatostatin receptor 1)  *受體1(SSTR1)抗體
SSTR2 (somatostatin receptor 2)  *受體2抗體
SSTR3 (somatostatin receptor 3)  *受體3抗體
SSTR4(somatostatin receptor 4)  *受體4抗體
SSTR5 (somatostatin receptor 5)  *受體5抗體
STAT1（signal transduceBYK and activatoBYK of transcription 1）  信號轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
phospho-STAT1(p-Tyr701)  抗磷酸化信號轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
STAT2 (signal transduceBYK and activatoBYK of transduction2)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子2(STAT2)抗體
STEAP1（Six transmbrane epithelial antigen of the prostate 1）  前列腺跨膜上皮1抗原抗體
phospho-STAT3(pThr705)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
phospho-STAT5a(pThr694)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5a抗體
phospho-STAT6(pThr641)  抗磷酸化信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
STAT3 (signal transduceBYK and activatoBYK of transduction 3)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
STAT4 (signal transduceBYK and activatoBYK of transduction 4)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子4抗體
STAT5 (signal transduceBYK and activatoBYK of transduction 5)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5(STAT5)抗體
STAT6 (signal transduceBYK and activatoBYK of transduction 6)  信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
Stra8(Stimulated by retinoic acid gene 8)  *激活基因8抗體
STRO-1  一種間充質(zhì)干細(xì)胞抗體
streptomycin  *抗體